Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
20.89
+1.99 (10.53%)
At close: Jun 26, 2026, 4:00 PM EDT
20.50
-0.39 (-1.87%)
After-hours: Jun 26, 2026, 7:02 PM EDT
Omada Health Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Omada Health stock have an average target of 23.2, with a low estimate of 18 and a high estimate of 30. The average target predicts an increase of 11.06% from the current stock price of 20.89.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Omada Health stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $30 | Buy | Reiterates | $30 | +43.61% | Jun 22, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $26 → $25 | Buy | Maintains | $26 → $25 | +19.67% | Jun 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | -4.26% | May 8, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | -4.26% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $22 → $24 | Buy | Maintains | $22 → $24 | +14.89% | May 8, 2026 |
Financial Forecast
Revenue This Year
327.31M
from 260.21M
Increased by 25.79%
Revenue Next Year
392.53M
from 327.31M
Increased by 19.93%
EPS This Year
0.33
from 0.15
Increased by 110.87%
EPS Next Year
0.48
from 0.33
Increased by 45.89%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 330.5M | 410.3M | |
| Avg | 327.3M | 392.5M | |
| Low | 325.0M | 380.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 27.0% | 25.3% | |
| Avg | 25.8% | 19.9% | |
| Low | 24.9% | 16.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 0.33 | 0.48 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 110.9% | 45.9% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.